178 related articles for article (PubMed ID: 35379578)
1. Homozygous familial hypercholesterolemia in China: Genetic and clinical characteristics from a real-world, multi-center, cohort study.
Jiang L; Stoekenbroek RM; Zhang F; Wang Q; Yu W; Yuan H; Cai G; Chen Y; Li G; Yang Y; Zhang Y; Cheng X; Zhu H; Zhou H; Ye P; Yan S; Wang X; Wu W; Li R; Xie J; Jiao J; Cheng S; Niu W; Chen J; Yang S; Zhou Y; Kastelein JJP; Yang Y; Wang L
J Clin Lipidol; 2022; 16(3):306-314. PubMed ID: 35379578
[TBL] [Abstract][Full Text] [Related]
2. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
Cuchel M; Lee PC; Hudgins LC; Duell PB; Ahmad Z; Baum SJ; Linton MF; de Ferranti SD; Ballantyne CM; Larry JA; Hemphill LC; Kindt I; Gidding SS; Martin SS; Moriarty PM; Thompson PP; Underberg JA; Guyton JR; Andersen RL; Whellan DJ; Benuck I; Kane JP; Myers K; Howard W; Staszak D; Jamison A; Card MC; Bourbon M; Chora JR; Rader DJ; Knowles JW; Wilemon K; McGowan MP
J Am Heart Assoc; 2023 May; 12(9):e029175. PubMed ID: 37119068
[TBL] [Abstract][Full Text] [Related]
3. Phenotype diversity among patients with homozygous familial hypercholesterolemia: A cohort study.
Raal FJ; Sjouke B; Hovingh GK; Isaac BF
Atherosclerosis; 2016 May; 248():238-44. PubMed ID: 27017151
[TBL] [Abstract][Full Text] [Related]
4. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
5. Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.
Wiegman A; Greber-Platzer S; Ali S; Reijman MD; Brinton EA; Charng MJ; Srinivasan S; Baker-Smith C; Baum S; Brothers JA; Hartz J; Moriarty PM; Mendell J; Bihorel S; Banerjee P; George RT; Hirshberg B; Pordy R
Circulation; 2024 Jan; 149(5):343-353. PubMed ID: 37860863
[TBL] [Abstract][Full Text] [Related]
6. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
Cuchel M; Bruckert E; Ginsberg HN; Raal FJ; Santos RD; Hegele RA; Kuivenhoven JA; Nordestgaard BG; Descamps OS; Steinhagen-Thiessen E; Tybjærg-Hansen A; Watts GF; Averna M; Boileau C; Borén J; Catapano AL; Defesche JC; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Ray KK; Stalenhoef AF; Stroes E; Taskinen MR; Wiegman A; Wiklund O; Chapman MJ;
Eur Heart J; 2014 Aug; 35(32):2146-57. PubMed ID: 25053660
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.
Reijman MD; Defesche JC; Wiegman A
Curr Opin Lipidol; 2023 Dec; 34(6):287-295. PubMed ID: 36752612
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the unique Chinese W483X mutation in the low-density lipoprotein-receptor gene in young patients with homozygous familial hypercholesterolemia.
Jiang L; Sun LY; Pan XD; Chen PP; Tang L; Wang W; Zhao LM; Yang SW; Wang LY
J Clin Lipidol; 2016; 10(3):538-546.e5. PubMed ID: 27206941
[TBL] [Abstract][Full Text] [Related]
9. The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study.
Luirink IK; Braamskamp MJAM; Wiegman A; Hartgers ML; Sjouke B; Defesche JC; Hovingh GK
J Clin Lipidol; 2019; 13(2):272-278. PubMed ID: 30795984
[TBL] [Abstract][Full Text] [Related]
10. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Cuchel M; Raal FJ; Hegele RA; Al-Rasadi K; Arca M; Averna M; Bruckert E; Freiberger T; Gaudet D; Harada-Shiba M; Hudgins LC; Kayikcioglu M; Masana L; Parhofer KG; Roeters van Lennep JE; Santos RD; Stroes ESG; Watts GF; Wiegman A; Stock JK; Tokgözoğlu LS; Catapano AL; Ray KK
Eur Heart J; 2023 Jul; 44(25):2277-2291. PubMed ID: 37130090
[TBL] [Abstract][Full Text] [Related]
11. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650
[TBL] [Abstract][Full Text] [Related]
12. A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study.
Stefanutti C; Pang J; Di Giacomo S; Wu X; Wang X; Morozzi C; Watts GF; Lin J
J Clin Lipidol; 2019; 13(4):608-617. PubMed ID: 31255589
[TBL] [Abstract][Full Text] [Related]
13. Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features.
Bertolini S; Calandra S; Arca M; Averna M; Catapano AL; Tarugi P;
Atherosclerosis; 2020 Nov; 312():72-78. PubMed ID: 32977124
[TBL] [Abstract][Full Text] [Related]
14. A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting.
Blom DJ; Gaudet D; Hegele RA; Patel DS; Cegla J; Kolovou G; Marin LM
Adv Ther; 2022 Apr; 39(4):1857-1870. PubMed ID: 35194765
[TBL] [Abstract][Full Text] [Related]
15. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.
Du Z; Li F; Jiang L; Li L; Du Y; Yu H; Luo Y; Wang Y; Sun H; Hu C; Li J; Yang Y; Jiao X; Wang L; Qin Y
BMC Med; 2023 Jul; 21(1):275. PubMed ID: 37501168
[TBL] [Abstract][Full Text] [Related]
16. [Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion].
Bilato C; Zambon A; Pisciotta L; Citroni N; Carubbi F; Zambon S; Zenti MG; Vinci P; Biolo G; Bonomo K; Egalini F; Passaro A; Nascimbeni F; Negri E; D'Addato S; Averna M; Arca M; Oliva F; Colivicchi F; Catapano A
G Ital Cardiol (Rome); 2023 Jan; 24(1):5-10. PubMed ID: 36573504
[TBL] [Abstract][Full Text] [Related]
17. Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia.
Chaudhry A; Trinder M; Vesely K; Cermakova L; Jackson L; Wang J; Hegele RA; Brunham LR
Circ Genom Precis Med; 2023 Apr; 16(2):e003887. PubMed ID: 36960729
[TBL] [Abstract][Full Text] [Related]
18. Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia.
Qiu HR; Zhang L; Zhu ZJ
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295590
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia.
Vuorio A; Tikkanen MJ; Kovanen PT
Vasc Health Risk Manag; 2014; 10():263-70. PubMed ID: 24851052
[TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
Foody JM; Vishwanath R
J Clin Lipidol; 2016; 10(4):970-986. PubMed ID: 27578130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
